RE: Conduit Pharmaceuticals Inc. (CDT) SEC Filing 10-Q Quarterly Report for the period ending Saturday, September 30, 202322 Nov 2023 17:29
Yes…at time of writing up 35% on good volume.
Worth noting that VELA got a good deal
on the put option ( as did CIZ) in that a subsequent valuation by CDT has shown it was overvalued by near $1m at the time it was first agreed .
This presumably because the chance of a commercial deal for the COVID aspect of the az drug has receded.
So the share price might be below par at the moment but upon exercise VELA will have many more shares than they may have had otherwise .
Good time to exercise on the turn upwards?